FDA recall record

ARBORYPHARM FOODS Natreve Vegan Protein Powder 10 servings, 13.1oz recall — FDA F-1428-2022

Undeclared allergen; milk.

Class Iclassification
F-1428-2022official record ID
Jul 20, 2022report date

Recall record at a glance

Official recordF-1428-2022
CategoryFood Recalls
ClassificationClass I
FDA record statusTerminated
Recalling firmARBORYPHARM FOODS Inc.
Report dateJul 20, 2022
Recall initiation dateJul 3, 2022
Quantity6,683 units
LocationVancouver, Canada

Official product description

Natreve Vegan Protein Powder 10 servings, 13.1oz (371g), UPC 628831120003 18 servings, 1.47lbs/23.53oz (667g), UPC 628831110073

Why the product was recalled

Undeclared allergen; milk.

Distribution information

U.S. distribution to the following: nationwide throughout the U.S. No foreign distribution.

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.